Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: Results from the Hisayama Study

Kidney International

Volumn 84, Issue 2, 2013, Pages 373-380

  Nakano, Toshiaki ^a,b   Ninomiya, Toshiharu ^a   Sumiyoshi, Shinji ^b   Onimaru, Mitsuho ^b   Fujii, Hiroshi ^b   Itabe, Hiroyuki ^c   Nakashima, Yutaka ^d   Sueishi, Katsuo ^e   Tsuruya, Kazuhiko ^a   Oda, Yoshinao ^a   Kitazono, Takanari ^a   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d FUKUOKA RED CROSS HOSPITAL   (Japan)

^e FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

Author keywords

Arteriosclerosis; Chronic kidney disease; Coronary artery disease; VEGF

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULOTROPIN;

AGED; AGING; ARTERY INTIMA; ARTICLE; AUTOPSY; BLEEDING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTRAPLAQUE HEMORRHAGE; JAPAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTOPSY; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; JAPAN; KIDNEY; LINEAR MODELS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; RUPTURE, SPONTANEOUS; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84881162759     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.111     Document Type: Article

References (42)

1. Iseki K, Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis 2000; 36: 820-825.
2. Ninomiya T, Kiyohara Y, Kubo M et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228-236. (Pubitemid 43181380)
3. Weiner DE, Tabatabai S, Tighiouart H et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401. (Pubitemid 44247251)
4. Joki N, Hase H, Nakamura R et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723. (Pubitemid 27170426)
5. Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148. (Pubitemid 41710326)
6. Lindner A, Charra B, Sherrard DJ et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701.
7. Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-223. (Pubitemid 30064276)
8. Gross ML, Meyer HP, Ziebart H et al. Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2007; 2: 121-134.
9. Nakamura S, Ishibashi-Ueda H, Niizuma S et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900.
10. Nakano T, Ninomiya T, Sumiyoshi S et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama Study. Am J Kidney Dis 2010; 55: 21-30.
11. Drüeke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol 2010; 6: 723-735.
12. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 2316-2325. (Pubitemid 37509739)
13. Katsuki S. Epidemiological and clinicopathological study on cerebrovascular disease in Japan. Prog Brain Res 1966; 21: 64-89.
14. Kubo M, Kiyohara Y, Kato I et al. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama Study. Kidney Int 2003; 63: 1508-1515. (Pubitemid 36350017)
15. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
16. Virmani R, Kolodgie FD, Burke AP et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061. (Pubitemid 41416300)
17. Buzello M, Tornig J, Faulhaber J et al. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14: 311-316. (Pubitemid 36150854)
18. Bro S, Bentzon JF, Falk E et al. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 2003; 14: 2466-2474. (Pubitemid 37169332)
19. Massy ZA, Ivanovski O, Nguyen-Khoa T et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109-116. (Pubitemid 43073162)
20. Oberg BP, McMenamin E, Lucas FL et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016. (Pubitemid 38251077)
21. Ok E, Basnakian AG, Apostolov EO et al. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int 2005; 68: 173-178. (Pubitemid 43181374)
22. Wang Z, Nicholls SJ, Rodriguez ER et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007; 13: 1176-1184. (Pubitemid 47530630)
23. Meier P, Golshayan D, Blanc E et al. Oxidized LDL modulates apoptosis of regulatory t cells in patients with ESRD. J Am Soc Nephrol 2009; 20: 1368-1384.
24. Itabe H, Takeshima E, Iwasaki H et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 1994; 269: 15274-15279.
25. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792.
26. Maggi E, Bellazzi R, Gazo A et al. Autoantibodies against oxidativelymodified LDL in uremic patients undergoing dialysis. Kidney Int 1994; 46: 869-876. (Pubitemid 24272047)
27. Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009; 218: 7-29.
28. Chen YX, Nakashima Y, Tanaka K et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 1999; 19: 131-139. (Pubitemid 29031921)
29. Celletti FL, Waugh JM, Amabile PG et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425-429. (Pubitemid 32298544)
30. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794-814. (Pubitemid 29411709)
31. Ramos MA, Kuzuya M, Esaki T et al. Induction of macrophage vegf in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998; 18: 1188-1196. (Pubitemid 28323605)
32. Pawlak K, Mysliwiec M, Pawlak D. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine 2008; 43: 98-101.
33. Miyagi M, Ishii H, Murakami R et al. Impact of renal function on coronary plaque composition. Nephrol Dial Transplant 2010; 25: 175-181.
34. Baber U, Stone GW, Weisz G et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5: S53-S61.
35. Kono K, Fujii H, Nakai K et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012; 82: 344-351.
36. Ueda K, Omae T, Hirota Y et al. Epidemiological and clinco-pathological study on renal diseases observed in the autopsy cases in Hisayama population, Kyushu Island, Japan. J Chronic Dis 1976; 29: 159-173.
37. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
38. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
39. Imai E, Horio M, Nitta K et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41-50. (Pubitemid 46474965)
40. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
41. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355-1374.
42. Nakano T, Nakashima Y, Yonemitsu Y et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 2005; 36: 330-340. (Pubitemid 40591802)